Balanced news tone
News Sentiment
UG sentiment intelligence
United-Guardian Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-1.2% over one week, +2.3% over four weeks, trend active, and near fair-value range.
Responsive Playbooks and the UG Inflection
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Responsive Playbooks and the UG Inflection
This article analyzes United-guardian Inc. (NYSE: UG), highlighting a positive near-term sentiment but overall weak alignment, with a mid-channel oscillation pattern. AI models have generated three trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to diffe
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 10 Jul 2026 22:42
- Source
- Stock Traders Daily
Understanding the Setup: (UG) and Scalable Risk
This article analyzes United-Guardian Inc. (NYSE: UG), highlighting positive near-term sentiment despite broader weak alignment and a mid-channel oscillation pattern. It identifies an exceptional 46.5:1 risk-reward short setup, targeting a 12.6% downside versus 0.3% risk. The pie
- Tone
- Negative 29/100
- Event
- Market update
- Published
- 29 Jun 2026 11:32
- Source
- Stock Traders Daily
Price to sales forward of United-Guardian, Inc. – NASDAQ:UG
This article provides financial data for United-Guardian, Inc. (NASDAQ: UG), specifically focusing on its forward price-to-sales ratio. It appears to be a data point or financial metric displayed on the TradingView platform for this specialty chemicals company.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 11:09
- Source
- TradingView
United-Guardian Inc. (UG) Q2 2025 Earnings: EPS of $0.14 Reported; Stock Edges Higher - Earnings Call Transcript
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 27 Jun 2026 07:00
- Source
- dars.gov.et
United-Guardian Inc. (UG) Shows Mild Uptick, Testing Key Resistance at $7.52 - Conversion Trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 07:00
- Source
- Bölüm Sonu Canavarı
Enterprise value to revenue forward of United-Guardian, Inc. – NASDAQ:UG
This article displays financial information for United-Guardian, Inc. (NASDAQ:UG), specifically focusing on its enterprise value to revenue forward. The content is presented within the TradingView platform, an interface for market data and financial analysis. It's concise and pri
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 11:12
- Source
- TradingView
United-Guardian Inc (UG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed revenue breakdown for United-Guardian Inc (UG) by business segment and geographical region. It highlights that Pharmaceuticals account for the largest proportion of revenue at 59.04%, followed by Cosmetic Ingredients and Medical. The United States
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 11:10
- Source
- TradingKey
United-Guardian Inc (UG) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for United-Guardian Inc (UG), noting its current risk assessment score of 4.12, ranking 92 out of 157 in the Pharmaceuticals industry. The company's beta of 0.97 suggests it tends to underperform in up markets but has smaller declines in do
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Jun 2026 10:39
- Source
- TradingKey
United-Guardian Inc (UG) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for United-Guardian Inc (UG), noting that no specific earnings forecast score is currently available for the company. It highlights that the Pharmaceuticals industry's average score is 7.84 and that relevant data for financial forecastin
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 01:09
- Source
- TradingKey
United-Guardian Inc (UG) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of United-Guardian Inc (UG), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. While the stock currently shows a neutral signal from most indicators, its moving averages su
- Tone
- Negative 42/100
- Event
- Market update
- Published
- 17 Jun 2026 01:09
- Source
- TradingKey
United-Guardian Inc. (UG) Edges Lower: Support Levels in Focus After a 1% Decline - Scalping Stock Signals
- Tone
- Negative 18/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- DonanımHaber
Precision Trading with United-guardian Inc. (UG) Risk Zones
This article from Stock Traders Daily provides a detailed analysis of United-guardian Inc. (UG), highlighting a strong 46.5:1 risk-reward short setup. It outlines three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profi
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 07 Jun 2026 08:50
- Source
- Stock Traders Daily
UG - United-Guardian Inc Dividends
This article provides detailed financial data and performance metrics for United-Guardian Inc. (UG), including its latest stock price, dividend details, market capitalization, and various financial ratios. It also outlines the company's historical performance, insider ownership,
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 06 Jun 2026 21:12
- Source
- Finviz
United-Guardian Inc. (UG) Q2 2025 Earnings: EPS of $0.14 Reported Amidst Stock Decline - Earnings Growth Analysis
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 May 2026 07:00
- Source
- DonanımHaber
United-Guardian Inc. (UG) Slides 1.13% as Stock Tests Key Support Zone - Retracement Entry
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- DonanımHaber
UG News | UNITED GUARDIAN INC (NASDAQ:UG)
This article provides news and analysis for UNITED GUARDIAN INC (NASDAQ:UG). It highlights the company's stock information, including its current price and recent performance. The latest news mentions United-Guardian's Q1 earnings rise year-over-year due to strong Renacidin deman
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 23 May 2026 03:09
- Source
- ChartMill
United-Guardian Q1 Earnings Rise Y/Y on Strong Renacidin Demand
United-Guardian Inc. reported a significant increase in Q1 2026 earnings, with net sales up 15.8% and net income climbing 46% year-over-year, largely driven by strong demand for its pharmaceutical product Renacidin and increased cosmetic ingredient sales through Ashland Specialty
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 18 May 2026 13:39
- Source
- Market source
United-Guardian elects directors and approves annual proposals at shareholder meeting
United-Guardian, Inc. (NASDAQ:UG) held its 2026 Annual Meeting of Stockholders, where shareholders elected seven directors and approved holding an annual advisory vote on executive compensation. They also approved the company's executive compensation and ratified the appointment
- Tone
- Positive 76/100
- Event
- Market update
- Published
- 16 May 2026 12:39
- Source
- Investing.com
United-Guardian (NASDAQ: UG) lifts Q1 2026 profit on pharma growth
United-Guardian (NASDAQ: UG) reported a significant increase in Q1 2026 net sales and net income, primarily driven by stronger pharmaceutical and cosmetic ingredient sales, including a one-time settlement payment. Net sales rose 16% to $2.87 million, and net income increased to $
- Tone
- Positive 77/100
- Event
- Earnings
- Published
- 12 May 2026 12:40
- Source
- Stock Titan
Renacidin demand, Ashland orders lift United-Guardian Q1 profit
United-Guardian (NASDAQ:UG) reported a strong first quarter in 2026, with net sales increasing by 15.8% to $2.87 million and net income rising by 46.0% to $818,902 ($0.18 per share) compared to Q1 2025. This growth was primarily driven by a 24% increase in pharmaceutical sales, s
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 May 2026 09:09
- Source
- Stock Titan
United-Guardian Soars in Q1 on Pharma, Cosmetics Rebound
United-Guardian, Inc. (NASDAQ:UG) reported a strong first-quarter performance with net sales up 15.8% to $2.87 million and net income soaring 46% to $818,902, or $0.18 per share. This growth was fueled by a 24% increase in pharmaceutical sales, specifically for Renacidin®, and a
- Tone
- Positive 89/100
- Event
- Market update
- Published
- 08 May 2026 13:40
- Source
- BriefGlance
Stronger Q1 2026 lifts profit at United-Guardian (NASDAQ: UG)
United-Guardian (NASDAQ: UG) reported significantly improved Q1 2026 results, with net sales increasing to $2,872,222 and net income rising to $818,902, or $0.18 per share. This performance was driven by stronger sales of pharmaceuticals and cosmetic ingredients, along with a one
- Tone
- Positive 73/100
- Event
- Earnings
- Published
- 08 May 2026 13:09
- Source
- Stock Titan
United-Guardian: Q1 Earnings Snapshot
United-Guardian Inc. (UG) reported its first-quarter earnings, totaling $819,000. The cosmetic ingredients maker announced a net income of 18 cents per share and generated revenue of $2.9 million for the period.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 13:03
- Source
- WKYC
United-Guardian (NASDAQ:UG) Has Announced A Dividend Of $0.25
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 01 Feb 2026 08:00
- Source
- simplywall.st
United-Guardian Inc. (UG) Share Price Today | United-Guardian (UG) Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Oct 2022 22:59
- Source
- Value Research